Aktie A2QQFZ ARYA SCIENCES ACQUISITION CORP IV
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen ARYA Sciences Acquisition Corp IV

Aktien

A2QQFZ

KYG316591083

ARYD

Markt geschlossen - Nasdaq
Andere Börsenplätze
 22:30:00 01.05.2024 		% 5 Tage % 1. Jan.
11,35 USD +0,18 % Intraday Chart für ARYA Sciences Acquisition Corp IV +0,18 % +4,13 %
29.03. ARYA Sciences Acquisition Corp IV berichtet über die Ergebnisse für das am 31. Dezember 2023 endende Geschäftsjahr CI
2023 ARYA Sciences Acquisition Corp IV meldet Ergebnis für das dritte Quartal und die neun Monate bis zum 30. September 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
ARYA Sciences Acquisition IV : G220229/S002/A001 - Form 8-K
ARYA Sciences Acquisition Corp IV Reports Earnings Results for the Full Year Ended December 31, 2023
ARYA Sciences Acquisition IV : Failure to Satisfy Listing Rule - Form 8-K
Adagio Medical To List on Nasdaq Through Business Combination with ARYA Sciences Acquisition Corp IV, Enabling Further Commercial and Clinical Development of Innovative Cardiac Ablation Technologies
ARYA Sciences Acquisition Corp IV announced that it has received $1 million in funding from ARYA Sciences Holdings IV
ARYA Sciences Acquisition Corp IV Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
ARYA Sciences Acquisition IV : New Financial Obligation - Form 8-K
ARYA Sciences Acquisition Corp IV announced that it has received $0.9 million in funding from ARYA Sciences Holdings IV
ARYA Sciences Acquisition IV : New Financial Obligation - Form 8-K
ARYA Sciences Acquisition Corp IV Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
ARYA Sciences Acquisition IV : New Financial Obligation - Form 8-K
ARYA Sciences Acquisition Corp V will redeem its Class A Ordinary Shares and will not consummate an initial business combination
ARYA Sciences Acquisition Corp IV announced that it has received $0.14 million in funding from ARYA Sciences Holdings IV
ARYA Sciences Acquisition Corp IV Reports Earnings Results for the First Quarter Ended March 31, 2023
ARYA SCIENCES ACQUISITION CORP IV Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)
ARYA Sciences Acquisition Corp IV Reports Earnings Results for the Full Year Ended December 31, 2022
ARYA Sciences Acquisition Corp IV Auditor Raises 'Going Concern' Doubt
ARYA Sciences Acquisition IV : Non-Reliance on Previously Issued Financial Report - Form 8-K
ARYA SCIENCES ACQUISITION CORP IV : Non-Reliance on Previous Financials, Audits or Interim Review (form 8-K)
ARYA SCIENCES ACQUISITION CORP IV : Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2QQFZ Aktie
  4. Nachrichten ARYA Sciences Acquisition Corp IV
  5. Andere Sprachen